STOCK TITAN

Yorkville Reports 38.6M Strive Shares, Holds 9.9% Stake

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

YA II and affiliated entities reported beneficial ownership of 38,576,603 shares of Class A common stock of Strive, Inc., representing 9.9% of the class. The total includes 17,250,000 outstanding Class A shares directly held plus 21,326,603 shares acquirable on exercise of warrants subject to a blocker that prevents exercise above 9.99%. The filing cites a base share count of 364,825,582 common shares outstanding as of September 12, 2025 and a conversion-limit adjusted total of 386,152,185 for calculating the percentage. The reporting persons are affiliated investment vehicles and principals within the Yorkville group; Mark Angelo is named as the individual who makes investment decisions. Signatures are dated October 7, 2025.

Positive

  • Clear disclosure of total beneficial ownership including warrant exposure (38,576,603 shares, 9.9%)
  • Structured blocker limits immediate dilution risk from warrant exercise by preventing conversion above 9.99%

Negative

  • Substantial warrant exposure (21,326,603) could convert into shares if the blocker is removed, increasing outstanding float
  • Concentrated ownership by affiliated entities approaches 10%, which could attract market or governance scrutiny

Insights

Yorkville-affiliated investors disclose a near-10% position in Strive, concentrated in shares plus exercisable warrants.

The group reports beneficial ownership of 38,576,603 shares, which the filing explains as 17,250,000 directly held shares plus 21,326,603 warrant-linked shares constrained by a 9.99% exercise blocker. This structure means the group currently counts warrants toward beneficial ownership for disclosure, while limiting actual conversion to avoid crossing the 10% threshold.

The position is material to investors because it approaches the ownership level that often draws regulatory or market attention. Watch for any amendment removing the exercise blocker or conversions that would change the reported 9.9% stake; such actions would be directly monitorable in subsequent filings over the near term (weeks to months).






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person: The reported holding consists of 17,250,000 shares of Class A Common Stock, $0.001 par value pr share (the "Common Stock") of Strive, Inc. (the "Issuer") plus 21,326,603 additional shares of Common Stock held in warrants exercisable for Common Stock with a blocker preventing exercise that would cause YA II to exceed 9.99%. The outstanding shares include (1) 364,825,582 shares of Common Stock outstanding as of September 12, 2025 as indicated in the registration statement published on September 15, 2025, and (2) 21,326,603 shares acquirable by YA II through exercise of warrants held, up to the conversion limit for a total of 386,152,185 shares outstanding.


SCHEDULE 13G




Comment for Type of Reporting Person: The reported holding consists of 17,250,000 shares of Class A Common Stock, $0.001 par value pr share (the "Common Stock") of Strive, Inc. (the "Issuer") plus 21,326,603 additional shares of Common Stock held in warrants exercisable for Common Stock with a blocker preventing exercise that would cause YA II to exceed 9.99%. The outstanding shares include (1) 364,825,582 shares of Common Stock outstanding as of September 12, 2025 as indicated in the registration statement published on September 15, 2025, and (2) 21,326,603 shares acquirable by YA II through exercise of warrants held, up to the conversion limit for a total of 386,152,185 shares outstanding.


SCHEDULE 13G




Comment for Type of Reporting Person: The reported holding consists of 17,250,000 shares of Class A Common Stock, $0.001 par value pr share (the "Common Stock") of Strive, Inc. (the "Issuer") plus 21,326,603 additional shares of Common Stock held in warrants exercisable for Common Stock with a blocker preventing exercise that would cause YA II to exceed 9.99%. The outstanding shares include (1) 364,825,582 shares of Common Stock outstanding as of September 12, 2025 as indicated in the registration statement published on September 15, 2025, and (2) 21,326,603 shares acquirable by YA II through exercise of warrants held, up to the conversion limit for a total of 386,152,185 shares outstanding.


SCHEDULE 13G




Comment for Type of Reporting Person: The reported holding consists of 17,250,000 shares of Class A Common Stock, $0.001 par value pr share (the "Common Stock") of Strive, Inc. (the "Issuer") plus 21,326,603 additional shares of Common Stock held in warrants exercisable for Common Stock with a blocker preventing exercise that would cause YA II to exceed 9.99%. The outstanding shares include (1) 364,825,582 shares of Common Stock outstanding as of September 12, 2025 as indicated in the registration statement published on September 15, 2025, and (2) 21,326,603 shares acquirable by YA II through exercise of warrants held, up to the conversion limit for a total of 386,152,185 shares outstanding.


SCHEDULE 13G




Comment for Type of Reporting Person: The reported holding consists of 17,250,000 shares of Class A Common Stock, $0.001 par value pr share (the "Common Stock") of Strive, Inc. (the "Issuer") plus 21,326,603 additional shares of Common Stock held in warrants exercisable for Common Stock with a blocker preventing exercise that would cause YA II to exceed 9.99%. The outstanding shares include (1) 364,825,582 shares of Common Stock outstanding as of September 12, 2025 as indicated in the registration statement published on September 15, 2025, and (2) 21,326,603 shares acquirable by YA II through exercise of warrants held, up to the conversion limit for a total of 386,152,185 shares outstanding.


SCHEDULE 13G




Comment for Type of Reporting Person: The reported holding consists of 17,250,000 shares of Class A Common Stock, $0.001 par value pr share (the "Common Stock") of Strive, Inc. (the "Issuer") plus 21,326,603 additional shares of Common Stock held in warrants exercisable for Common Stock with a blocker preventing exercise that would cause YA II to exceed 9.99%. The outstanding shares include (1) 364,825,582 shares of Common Stock outstanding as of September 12, 2025 as indicated in the registration statement published on September 15, 2025, and (2) 21,326,603 shares acquirable by YA II through exercise of warrants held, up to the conversion limit for a total of 386,152,185 shares outstanding.


SCHEDULE 13G




Comment for Type of Reporting Person: The reported holding consists of 17,250,000 shares of Class A Common Stock, $0.001 par value pr share (the "Common Stock") of Strive, Inc. (the "Issuer") plus 21,326,603 additional shares of Common Stock held in warrants exercisable for Common Stock with a blocker preventing exercise that would cause YA II to exceed 9.99%. The outstanding shares include (1) 364,825,582 shares of Common Stock outstanding as of September 12, 2025 as indicated in the registration statement published on September 15, 2025, and (2) 21,326,603 shares acquirable by YA II through exercise of warrants held, up to the conversion limit for a total of 386,152,185 shares outstanding.


SCHEDULE 13G




Comment for Type of Reporting Person: The reported holding consists of 17,250,000 shares of Class A Common Stock, $0.001 par value pr share (the "Common Stock") of Strive, Inc. (the "Issuer") plus 21,326,603 additional shares of Common Stock held in warrants exercisable for Common Stock with a blocker preventing exercise that would cause YA II to exceed 9.99%. The outstanding shares include (1) 364,825,582 shares of Common Stock outstanding as of September 12, 2025 as indicated in the registration statement published on September 15, 2025, and (2) 21,326,603 shares acquirable by YA II through exercise of warrants held, up to the conversion limit for a total of 386,152,185 shares outstanding.


SCHEDULE 13G



YA II PN, Ltd.
Signature:/s/ David Gonzalez
Name/Title:David Gonzalez, General Counsel
Date:10/07/2025
YA Global Investments II (U.S.), LP
Signature:/s/ David Gonzalez
Name/Title:David Gonzalez, General Counsel
Date:10/07/2025
Yorkville Advisors Global, LP
Signature:/s/ David Gonzalez
Name/Title:David Gonzalez, General Counsel
Date:10/07/2025
Yorkville Advisors Global II, LLC
Signature:/s/ David Gonzalez
Name/Title:David Gonzalez, General Counsel
Date:10/07/2025
YAII GP, LP
Signature:/s/ David Gonzalez
Name/Title:David Gonzalez, General Counsel
Date:10/07/2025
YAII GP II, LLC
Signature:/s/ David Gonzalez
Name/Title:David Gonzalez, General Counsel
Date:10/07/2025
Mark Angelo
Signature:/s/ Mark Angelo
Name/Title:Mark Angelo
Date:10/07/2025
SC-Sigma Global Partners, LP
Signature:/s/ David Gonzalez
Name/Title:David Gonzalez, General Counsel
Date:10/07/2025

FAQ

What stake did Yorkville report in Strive, Inc. (ASST)?

The Yorkville group reported beneficial ownership of 38,576,603 shares, equal to 9.9% of Class A common stock on a conversion-adjusted basis.

How is the 38,576,603 share figure composed?

It consists of 17,250,000 directly held Class A shares plus 21,326,603 shares acquirable upon exercise of warrants, subject to an exercise blocker.

What prevents immediate exercise of the warrants?

The filing states a blocker that prevents warrant exercise that would cause YA II to exceed 9.99% ownership.

What share counts were used to calculate the percentage ownership?

The filing uses 364,825,582 outstanding common shares as of September 12, 2025 and a conversion-adjusted total of 386,152,185 for the percentage calculation.

Who makes the investment decisions for the reporting group?

The filing names Mark Angelo as the individual who makes investment decisions on behalf of YA II.
Strive

NASDAQ:ASST

View ASST Stock Overview

ASST Rankings

ASST Latest News

ASST Latest SEC Filings

ASST Stock Data

600.85M
52.14M
Asset Management
Finance Services
Link
United States
DALLAS